{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:55:44Z","timestamp":1780102544392,"version":"3.54.0"},"reference-count":96,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Factor XIII-A (FXIII-A) deficiency is an ultra-rare bleeding disorder characterized by high rates of morbidity and mortality, primarily resulting from intracranial hemorrhage, umbilical cord bleeding, and miscarriage, whereas patients with severe FXIII-B deficiency present with a milder phenotype. Although the estimated incidence of severe FXIII-A deficiency is one per 2 million, a high prevalence ranging from 0.8 to 3.5% has been observed for heterozygous FXIII-A deficiency. Unlike most bleeding disorders, individuals with heterozygous FXIII-A deficiency, particularly women, are more likely to experience hemorrhagic complications during hemostatic challenges. About 200 Mutations have been observed in F13A and F13B genes, with most being missense mutations, while large deletions are the rarest. There is no correlation between genotype and phenotype and a moderate to strong correlation between factor activity and clinical severity in FXIII-A deficiency, making it difficult to predict bleeding patterns based on genotype and FXIII activity levels. Primary prophylaxis is mandatory for all patients with severe FXIII-A deficiency, while those with heterozygous deficiency are generally asymptomatic and may require on-demand therapy during hemostatic challenges, most commonly in women. On the other hand, patients with severe FXIII-B deficiency may only require on-demand therapy, while heterozygotes are generally asymptomatic. Although there are general recommended therapeutic regimens for prophylaxis or on-demand therapy in different situations, personalized pharmacokinetic-based replacement therapy represents the optimal approach that can optimize intervention efficacy. In such an approach, several factors may affect the effectiveness of treatment and determine the dose and type of intervention, including the classification of FXIII deficiency, residual plasma levels of FXIII, clinical situation requiring intervention, age, weight, and also gender.<\/jats:p>","DOI":"10.1055\/s-0044-1796673","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:23:54Z","timestamp":1732926234000},"page":"155-169","source":"Crossref","is-referenced-by-count":6,"title":["Factor XIII Deficiency: Laboratory, Molecular, and Clinical Aspects"],"prefix":"10.1055","volume":"51","author":[{"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[{"name":"Hamin Pazhuhan Tis Institute, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Jozdani","sequence":"additional","affiliation":[{"name":"Department of Hematology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh Kiani","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Department of Hematology, High Institute for Education and Research in Transfusion Medicine, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","article-title":"Blood coagulation factor XIII and factor XIII deficiency","volume":"30","author":"A Dorgalaleh","year":"2016","journal-title":"Blood Rev"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0038-1676580","article-title":"A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: Khash factor XIII","volume":"45","author":"A Dorgalaleh","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"ref3","volume-title":"World Federation of Hemophilia Report on the Annual Global Survey 2022","author":"World Federation of Hemophilia.","year":"2022"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jtha.2023.09.032","article-title":"Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency","volume":"22","author":"S Singh","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Diagnosis and classification of factor XIII deficiencies","volume":"9","author":"H P Kohler","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0036-1572326","article-title":"Diagnosis and management of congenital and acquired FXIII deficiencies","volume":"42","author":"L Muszbek","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-014-1664-1","article-title":"Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency","volume":"100","author":"M Naderi","year":"2014","journal-title":"Int J Hematol"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0043-1764471","article-title":"Novel insights into heterozygous factor XIII deficiency","volume":"50","author":"A Dorgalaleh","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","article-title":"Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control","volume":"95","author":"A Ichinose","year":"2012","journal-title":"Int J Hematol"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2516.2010.02207.x","article-title":"Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency","volume":"16","author":"V Ivaskevicius","year":"2010","journal-title":"Haemophilia"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/ijlh.12633","article-title":"Detection of factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories","volume":"39","author":"I Jennings","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"034","DOI":"10.1055\/s-0043-1761217","article-title":"The history of factor XIII deficiency","volume":"50","author":"A Dorgalaleh","year":"2024","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/plac.1999.0489","article-title":"Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell","volume":"21","author":"T Asahina","year":"2000","journal-title":"Placenta"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH05-04-0291","article-title":"Impaired wound healing in factor XIII deficient mice","volume":"94","author":"A Inbal","year":"2005","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/01.ATV.0000081636.25235.C6","article-title":"Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression","volume":"23","author":"R Dardik","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/JBM.S32693","article-title":"New developments in the management of congenital factor XIII deficiency","volume":"4","author":"Z Fadoo","year":"2013","journal-title":"J Blood Med"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2010.04070.x","article-title":"Factor XIII: novel structural and functional aspects","volume":"9","author":"I Kom\u00e1romi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/biom10060914","article-title":"The structure of blood coagulation factor XIII is adapted to oxidation","volume":"10","author":"A Vasilyeva","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/biom9120765","article-title":"The plasma factor XIII heterotetrameric complex structure: unexpected unequal pairing within a symmetric complex","volume":"9","author":"S Singh","year":"2019","journal-title":"Biomolecules"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hae.12298","article-title":"Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH\/SSC guidelines","volume":"20","author":"M Souri","year":"2014","journal-title":"Haemophilia"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jb\/mvs088","article-title":"Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII","volume":"152","author":"S Maeda","year":"2012","journal-title":"J Biochem"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3324\/haematol.2009.017210","article-title":"Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function","volume":"95","author":"V Ivaskevicius","year":"2010","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"101029","DOI":"10.1016\/j.blre.2022.101029","article-title":"Molecular basis of rare congenital bleeding disorders","volume":"59","author":"A Dorgalaleh","year":"2023","journal-title":"Blood Rev"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.thromres.2012.05.003","article-title":"Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency","volume":"130","author":"M Souri","year":"2012","journal-title":"Thromb Res"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood.V87.1.141.141","article-title":"Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit","volume":"87","author":"H Mikkola","year":"1996","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"101032","DOI":"10.1016\/j.blre.2022.101032","article-title":"Genetic landscape in coagulation factor XIII associated defects - advances in coagulation and beyond","volume":"59","author":"H Javed","year":"2023","journal-title":"Blood Rev"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2004.00908.x","article-title":"Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families","volume":"2","author":"A Vysokovsky","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12881-019-0944-2","article-title":"Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency","volume":"21","author":"J Deng","year":"2020","journal-title":"BMC Med Genet"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V91.1.149","article-title":"Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family","volume":"91","author":"R Anwar","year":"1998","journal-title":"Blood"},{"issue":"03","key":"ref30","first-page":"187","article-title":"Characterization of a large deletion that leads to congenital factor XIII deficiency [in Japanese]","volume":"56","author":"M Otaki","year":"2008","journal-title":"Rinsho Byori"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2516.2007.01517.x","article-title":"Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations","volume":"13","author":"V Ivaskevicius","year":"2007","journal-title":"Haemophilia"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12881-020-01111-0","article-title":"A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report","volume":"21","author":"R Cai","year":"2020","journal-title":"BMC Med Genet"},{"issue":"08","key":"ref33","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/ijms20081956","article-title":"Disruption of structural disulfides of coagulation FXIII-B subunit; functional implications for a rare bleeding disorder","volume":"20","author":"S Singh","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02983803","article-title":"Deficiency of factor XIII gene in Chinese: 3 novel mutations","volume":"78","author":"B Duan","year":"2003","journal-title":"Int J Hematol"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/hae.12340","article-title":"Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations","volume":"20","author":"M Borhany","year":"2014","journal-title":"Haemophilia"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcmd.2016.01.002","article-title":"Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations","volume":"57","author":"S Shanbhag","year":"2016","journal-title":"Blood Cells Mol Dis"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MBC.0000000000000374","article-title":"Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran","volume":"27","author":"M Naderi","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"08","key":"ref38","first-page":"1495","article-title":"Premarital screening program for congenital factor XIII deficiency in Iran","volume":"66","author":"M Daneshi","year":"2020","journal-title":"Clin Lab"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0034-1395350","article-title":"Factor XIII deficiency in Iran: a comprehensive review of the literature","volume":"41","author":"A Dorgalaleh","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00277-009-0863-y","article-title":"Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect","volume":"89","author":"N Louhichi","year":"2010","journal-title":"Ann Hematol"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1055\/s-0038-1656112","article-title":"Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families","volume":"77","author":"A Inbal","year":"1997","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1160\/TH07-01-0034","article-title":"International registry on factor XIII deficiency: a basis formed mostly on European data","volume":"97","author":"V Ivaskevicius","year":"2007","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MBC.0000000000000171","article-title":"Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency","volume":"26","author":"M-A Jang","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/hae.14613","article-title":"Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features","volume":"28","author":"A Ichinose","year":"2022","journal-title":"Haemophilia"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00277-015-2568-8","article-title":"Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency","volume":"95","author":"A Dorgalaleh","year":"2016","journal-title":"Ann Hematol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-031-43156-2_2","volume-title":"Congenital bleeding disorders: diagnosis and management. In: Congenital Bleeding Disorders: Diagnosis and Management","author":"A Dorgalaleh","year":"2023"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1542\/peds.109.2.e32","article-title":"Delayed umbilical bleeding\u2013a presenting feature for factor XIII deficiency: clinical features, genetics, and management","volume":"109","author":"R Anwar","year":"2002","journal-title":"Pediatrics"},{"issue":"22","key":"ref48","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2020009472","article-title":"Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia","volume":"137","author":"A Casini","year":"2021","journal-title":"Blood"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01632360","article-title":"The fibrin stabilizing factor, factor XIII","volume":"26","author":"F Duckert","year":"1973","journal-title":"Blut"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hae.12368","article-title":"Rare coagulation factor deficiencies: a countrywide screening data from India","volume":"20","author":"S Shetty","year":"2014","journal-title":"Haemophilia"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0037-1604109","article-title":"Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency","volume":"44","author":"S ER Alavi","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ijlh.12789","article-title":"Prenatal diagnosis in rare bleeding disorders-an unresolved issue?","volume":"40","author":"S Tabibian","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"03","key":"ref53","first-page":"249","article-title":"Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review","volume":"12","author":"T C Singleton","year":"2012","journal-title":"Ochsner J"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"L A Sharief","year":"2013","journal-title":"Haemophilia"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2003-38832","article-title":"Coagulation factor deficiencies and pregnancy loss","volume":"29","author":"A Inbal","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.105.602094","article-title":"Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction","volume":"113","author":"M Nahrendorf","year":"2006","journal-title":"Circulation"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1023\/A:1005541512152","article-title":"Recombinant factor XIII improves established experimental colitis in rats","volume":"45","author":"G D'Argenio","year":"2000","journal-title":"Dig Dis Sci"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/ijms22063055","article-title":"Factor XIII-A: an indispensable \u201cfactor\u201d in haemostasis and wound healing","volume":"22","author":"F SM Alshehri","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MPH.0000000000001671","article-title":"Congenital factor XIII deficiency with the presence of inhibitor: a case study","volume":"43","author":"S Karaman","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000207801","article-title":"Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family","volume":"58","author":"A Girolami","year":"1977","journal-title":"Acta Haematol"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood.V87.7.2769.bloodjournal8772769","article-title":"Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain","volume":"87","author":"T Izumi","year":"1996","journal-title":"Blood"},{"issue":"09","key":"ref62","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood.V97.9.2667","article-title":"Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation","volume":"97","author":"S Koseki","year":"2001","journal-title":"Blood"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0037-1615173","article-title":"A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain","volume":"80","author":"M Souri","year":"1998","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V82.1.145.bloodjournal821145","article-title":"Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII","volume":"82","author":"T Hashiguchi","year":"1993","journal-title":"Blood"},{"key":"ref65","first-page":"341","volume-title":"Bleeding complications in heterozygotes with congenital factor XIII deficiency","author":"R Egbring","year":"1988"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-999040","article-title":"ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives","volume":"22","author":"R Seitz","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"ref67","first-page":"340","article-title":"Bleeding complications in patients with heterozygous FXIII subunit A deficiency?","volume":"6","author":"R Egbring","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MBC.0b013e328345f566","article-title":"Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran","volume":"22","author":"M Mahmoodi","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"07","key":"ref69","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/10245332.2015.1101975","article-title":"Diagnosis of factor XIII deficiency","volume":"21","author":"A Dorgalaleh","year":"2016","journal-title":"Hematology"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/labmed\/lmw046","article-title":"Comparison of 2 methods of clot solubility testing in detection of factor XIII deficiency","volume":"47","author":"A Dorgalaleh","year":"2016","journal-title":"Lab Med"},{"issue":"06","key":"ref71","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.transci.2018.07.006","article-title":"State of the art in factor XIII laboratory assessment","volume":"57","author":"M A Durda","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"05","key":"ref72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/emm.2002.55","article-title":"Effects of Val34Leu and Val35Leu polymorphism on the enzyme activity of the coagulation factor XIII-A","volume":"34","author":"I H Lee","year":"2002","journal-title":"Exp Mol Med"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0049-3848(01)00224-9","article-title":"Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency","volume":"102","author":"M Wilmer","year":"2001","journal-title":"Thromb Res"},{"issue":"15","key":"ref74","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.272.15.10311","article-title":"Hydrolysis of gamma:epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa","volume":"272","author":"K N Parameswaran","year":"1997","journal-title":"J Biol Chem"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ab.2007.05.011","article-title":"A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma","volume":"367","author":"K Oertel","year":"2007","journal-title":"Anal Biochem"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00784-013-1133-x","article-title":"Causes and timing of delayed bleeding after oral surgery","volume":"18","author":"C Czembirek","year":"2014","journal-title":"Clin Oral Investig"},{"issue":"08","key":"ref77","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/MBC.0000000000000505","article-title":"Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran","volume":"27","author":"M Naderi","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"08","key":"ref78","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/17474086.2020.1796622","article-title":"Pharmacological management of rare coagulation factor deficiencies besides hemophilia","volume":"13","author":"A Dorgalaleh","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref80","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"M Menegatti","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.4081\/hr.2021.8904","article-title":"Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program","volume":"13","author":"S Sarmiento Doncel","year":"2021","journal-title":"Hematol Rep"},{"issue":"11","key":"ref82","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/jth.13841","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds: comment","volume":"15","author":"A Dorgalaleh","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"A D Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"04","key":"ref84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11239-022-02700-x","article-title":"The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTOR\u21222 trial to a real-world study: a head-to-head comparison","volume":"54","author":"S Pasca","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"ref85","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jth.12739","article-title":"Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency","volume":"12","author":"B Kerlin","year":"2014","journal-title":"J Thromb Haemost"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(13)70005-7","article-title":"Corifact\u2122\/Fibrogammin\u00ae P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study","volume":"130","author":"D Nugent","year":"2012","journal-title":"Thromb Res"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0278-2391(85)90165-X","article-title":"Tooth extraction in two patients who had a congenital deficiency of factor XIII","volume":"43","author":"H Suzuki","year":"1985","journal-title":"J Oral Maxillofac Surg"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/trf.12784","article-title":"Use of factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures","volume":"55","author":"M Janbain","year":"2015","journal-title":"Transfusion"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1624581","article-title":"Recombinant FXIII (rFXIII-A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A-subunit deficiency","volume":"118","author":"M Carcao","year":"2018","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/jth.14795","article-title":"The impact of prepartum factor XIII activity on postpartum blood loss","volume":"18","author":"C Haslinger","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref91","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00404-018-4980-5","article-title":"The impact of antenatal factor XIII levels on postpartum haemorrhage: a prospective observational study","volume":"299","author":"C Bamberg","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"ref92","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s10072-015-2284-0","article-title":"Factor XIII deficiency and head trauma: management and therapy","volume":"36","author":"G Ribizzi","year":"2015","journal-title":"Neurol Sci"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1179\/1607845414Y.0000000172","article-title":"Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases","volume":"20","author":"M Naderi","year":"2015","journal-title":"Hematology"},{"issue":"08","key":"ref94","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1538-7836.2003.00338.x","article-title":"Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency","volume":"1","author":"M Lak","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2141.1990.00282.x-i1","article-title":"A familial factor XIII subunit B deficiency","volume":"74","author":"M Saito","year":"1990","journal-title":"Br J Haematol"},{"issue":"03","key":"ref96","first-page":"179","article-title":"A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency","volume":"20","author":"M G Capellato","year":"1987","journal-title":"Haematologia (Budap)"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1796673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:42:44Z","timestamp":1740008564000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1796673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":96,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1796673","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}